Make sure you share any worries you have so they can help you and make sure that your treatment fits your needs
KEY TAKEAWAYS GLP-1 medications require individualized medical evaluation, not one-size-fits-all prescribing Direct-to-consumer microdosing platforms lack FDA approval and proper medical oversight The erosion of trust in healthcare has created opportunities for unregulated treatments Comprehensive metabolic care includes regular lab work, body composition monitoring, and personalized treatment plans Technology should enhance medical care, not replace proper physician evaluation NOTABLE QUOTE "I see so many people that come in, you know, they're obsessed with monitoring their HRV, their heart rate variability, and yet they had no idea they have pre-diabetes and they had no idea that they have triglyceride levels through the roof." Dr
The future of BPC-157 is poised at a critical juncture
Conditions such as inflammatory bowel disease (IBD), leaky gut syndrome, celiac disease recovery, autoimmune diseases, and mast cell activation syndrome (MCAS) can be incredibly challenging to manage
We remain committed to guiding our patients toward achieving and maintaining a healthy weight, improved well-being, and an abundant life
